Surrogate Advertisements: Indirect Promotion of Prohibited and Restricted Products

Some products may be sold but not advertised, alcohol under State excise and media law, tobacco under COTPA, and the surrogate advertisement is the industry's answer: promote something else that carries the same brand, and let the brand do the selling. The 2022 Guidelines prohibit the device in terms, while leaving room for the genuine brand extension. This note explains the prohibition, the real-object test that separates extension from surrogate, the sports-sponsorship frontier, and enforcement.

1. The Device and the Prohibition

A surrogate advertisement promotes a product whose advertising is prohibited or restricted by law, indirectly, through an advertisement ostensibly for another product, service or event that shares the restricted product's brand name, logo, imagery or presentation: the whisky brand's 'club soda' and 'music CDs', the beer brand's 'packaged drinking water', the pan-masala house's 'elaichi' fronted by film stars, the gutkha family's silver-coated 'cardamom'. The 2022 Guidelines close it off in two movements: no surrogate or indirect advertisement shall be made for goods or services whose advertising is otherwise prohibited or restricted, by circumventing the prohibition through an advertisement for other goods or services; and an advertisement is treated as surrogate where the restricted product's brand, logo, colour, layout and presentation are used in a manner that effectively promotes it, or where the advertised item functions as a mere reminder of the restricted product. Behind the Guidelines stand the primary bars themselves, COTPA's advertising prohibition for tobacco, the broadcasting and State-law restrictions on alcohol advertising, and the 2023 extension of the policy to offshore betting and gambling promotion, which the CCPA and the information ministry have pursued through advisories to media, platforms and endorsers.

2. The Line: Genuine Brand Extension versus Surrogate

The prohibition cannot outlaw a brand's lawful diversification, so the line is drawn by the advertisement's real object. A genuine brand extension, a real product or service, genuinely manufactured, distributed and sold, advertised for its own sake, is lawful though it shares a name with a restricted product. The working indicators:

Commercial reality: does the advertised product exist at scale, production, distribution, revenue, or is it token stock whose advertising spend dwarfs its sales? The soda sold in a few crates behind a national campaign answers the question itself.
Proportionality: is the advertising expenditure proportionate to the extension's turnover, or explicable only as promotion of the restricted sibling?
Content and association: does the advertisement sell the extension's own qualities, or trade on the restricted product's imagery, the glass, the pour, the bar setting, the celebration cues, the exact bottle silhouette?
Distinct identity: a lawful extension tends to carry its own packaging and presentation; the surrogate replicates the restricted product's trade dress so the thirty-second spot reads as the original.
The burden: the advertiser claiming extension carries the burden of its bona fides, with the production and sales record as the proof; broadcasting self-regulation applies the same tests for what may air.

3. The Frontier: Sponsorship, Events and Influencers

The surrogate's modern habitat is sponsorship and sport: team and league sponsorships, fantasy and gaming tie-ins, and event branding that put restricted-product brands before mass audiences through their extension names; music labels, award nights and merchandise lines serve the same office. The regulatory response has been advisory-led: CCPA advisories warning advertisers, broadcasters and event organisers against surrogate campaigns around major tournaments; ministry advisories directing media and online platforms, including against offshore betting advertising and its surrogate 'news' and 'info' avatars; and the endorsement rules closing the influencer route, the celebrity who fronts an 'elaichi' campaign endorses what the net impression conveys, and the due-diligence and disclosure duties, with Section 21's penalties and endorsement bans, apply to the surrogate as to any misleading advertisement. For the examinee and the practitioner alike, the analytical sequence is constant: identify the restricted product; ask what the advertisement's net impression promotes; test the extension's commercial reality; and assign liability along the chain, principal, agency, endorser, platform.

⚠ Key point

The surrogate advertisement, promotion of a prohibited or restricted product through a brand-sharing stand-in, is prohibited by the 2022 Guidelines, which catch both the indirect promotion and the use of the restricted product's brand and presentation as a reminder. The one safe harbour is the genuine brand extension: a real product, really sold, advertised for itself, with proportionate spend and its own identity, and the burden of bona fides on the advertiser. Enforcement runs through CCPA advisories and Section 21 orders, the primary statutes (COTPA, excise and broadcast law), and the endorsement rules that reach the faces fronting the campaign.

4. Related Topics and Provisions

The 2022 Guidelines (Topic 72): the prohibition's instrument
Misleading advertisement under Section 2(28) (Topic 19): the net-impression standard applied
Endorser liability (Topics 29 and 76): the faces of surrogate campaigns
CCPA powers (Topics 26 and 28): advisories, penalties and discontinuance